Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: A population-based study

American Journal of Geriatric Cardiology

Volumn 16, Issue 1, 2007, Pages 15-23

  Berger, Alan K ^a,b   Duval, Susan J ^b   Armstrong, Chris ^b   Jacobs Jr , David R ^b,c   Luepker, Russell V ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; RESIN; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG UTILIZATION; FEMALE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ACUTE DISEASE; BLOOD; CLINICAL PRACTICE; DRUG USE; EPIDEMIOLOGY; HEALTH CARE QUALITY; HEART INFARCTION; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUG UTILIZATION REVIEW; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES;

EID: 33947503331     PISSN: 10767460     EISSN: 1751715X     Source Type: Journal    
DOI: 10.1111/j.1076-7460.2007.04886.x     Document Type: Article

References (26)

1. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial. JAMA. 2001;285:1711-1718.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44:E1-E211.
3. Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997;96:4211-4218.
4. Hunt D, Young P, Simes J, et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Ann Intern Med. 2001;134:931-940.
5. Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med. 1998;129:681-689.
6. Jackevicius CA, Anderson GM, Leiter L, et al. Use of the statins in patients after acute myocardial infarction: Does evidence change practice? Arch Intern Med. 2001;161:183-188.
7. Aronow WS. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl. Am J Cardiol. 1998;82:668-669, A6, A8.
8. Lemaitre RN, Furberg CD, Newman AB, et al. Time trends in the use of cholesterol-lowering agents in older adults: The Cardiovascular Health Study. Arch Intern Med. 1998;158:1761-1768.
9. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients. JAMA. 2004;291:1864-1870.
10. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467.
11. Wei L, Wang J, Thompson P, et al. Adherence to statin treatment and readmission of patients after myocardial infarction: A six-year follow-up study. Heart. 2002;88:229-233.
12. Fonarow GC, French WJ, Parsons LS, et al. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Circulation. 2001;103:38-44.
13. McGovern PG, Herlitz J, Pankow JS, et al. Comparison of medical care and one- and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America and Göteborg, Sweden. Am J Cardiol. 1997;80:557-562.
14. McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota Heart Survey. Circulation. 2001: 104: 19-24.
15. Jones P, Kafonek S, Laurora I, et al. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1998;81:582-587.
16. McKenney JM, Jones PH, Adamczyk MA, et al. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: Results from the STELLAR trial. Curr Med Res Opin. 2003;19:689-698.
17. Manolio TA, Pearson TA, Wenger NK, et al. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
18. Martin MJ, Hulley SB, Browner WS, et al. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men. Lancet. 1986;2:933-936.
19. Foody JM, Wang Y, Kiefe CI, et al. Long-term prognostic importance of total cholesterol in elderly survivors of an acute myocardial infarction: The Cooperative Cardiovascular Pilot Project. J Am Geriatr Soc. 2003;51:930-936.
20. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA. 1999;282:2340-2346.
21. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet. 2002;360:1623-1630.
22. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (Lipid-Lowering Trial) (ALLHAT-LLT). JAMA. 2002; 288: 2998-3007.
23. Kayikcioglu M, Turkoglu C, Kultursay H, et al. The short-term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction [abstract]. Circulation. 1999;100(suppl 1):I-303. Abstract 1586.
24. Arntz HR. The case for early statin therapy in acute coronary syndromes. Cardiol Rev. 2002;10:91-96.
25. Liem AH, van Boven AJ, Veeger NJ, et al. Effect of fluvastatin on ischaemia following acute myocardial infarction: A randomized trial. Eur Heart J. 2002;23:1931-1937.
26. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.